KalVista Pharmaceuticals, Inc. (KALV)

NASDAQ: KALV · IEX Real-Time Price · USD

10.35

-0.86 (-7.67%)

At close: Apr 24, 2024, 4:00 PM

10.25

-0.10 (-0.97%)

After-hours: Apr 24, 2024, 7:13 PM EDT

KalVista Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Equivalents	56.24	30.73	50.59	15.79	32.01	51.06	30.95	21.76	-	3.95	Upgrade
Short-Term Investments	93.14	135.47	198.34	51.93	68.81	0	0	0	-	0	Upgrade
Cash & Cash Equivalents	149.38	166.2	248.93	67.71	100.81	51.06	30.95	21.76	0	3.95	Upgrade
Cash Growth	-10.12%	-33.23%	267.62%	-32.83%	97.46%	64.96%	42.21%	-	-	-59.85%	Upgrade
Receivables	0	0	0	0	0	0	0.3	0.36	-	0	Upgrade
Other Current Assets	22.95	27.45	15.34	20.98	14.74	8.33	2.95	2.55	-	0.64	Upgrade
Total Current Assets	172.33	193.65	264.26	88.7	115.55	59.38	34.2	24.67	-	4.59	Upgrade
Property, Plant & Equipment	10.77	10.04	7.55	3.66	2.41	1.84	0.1	0.07	-	0.18	Upgrade
Other Long-Term Assets	0.11	0.19	0.2	0.18	0.17	0.17	0.05	0	-	1.88	Upgrade
Total Long-Term Assets	10.88	10.23	7.75	3.83	2.59	2.01	0.15	0.07	-	2.06	Upgrade
Total Assets	183.2	203.88	272.01	92.53	118.13	61.39	34.35	24.75	-	6.64	Upgrade
Accounts Payable	4.82	3.64	1.98	1.68	2.86	1.43	1.15	1.14	-	1.02	Upgrade
Deferred Revenue	0	0	0	0	12.89	29.34	0	0	-	0.11	Upgrade
Current Debt	0	0	0	0	0	0.22	0	0	-	4.44	Upgrade
Other Current Liabilities	10.22	7.94	7.79	6.04	2.31	-7.78	1.87	2.11	-	1.52	Upgrade
Total Current Liabilities	15.03	11.58	9.77	7.72	18.05	23.22	3.02	3.25	-	7.09	Upgrade
Long-Term Debt	7.15	7.21	5.05	1.06	0	0.06	0	0	-	2.13	Upgrade
Other Long-Term Liabilities	0	0	0	0	3.34	10.86	0	58.61	-	2.05	Upgrade
Total Long-Term Liabilities	7.15	7.21	5.05	1.06	3.34	10.92	0	58.61	-	4.18	Upgrade
Total Liabilities	22.18	18.79	14.82	8.78	21.39	34.14	3.02	61.86	-	11.27	Upgrade
Total Debt	7.15	7.21	5.05	1.06	0	0.28	0	0	-	6.57	Upgrade
Debt Growth	-0.92%	42.91%	377.39%	-	-	-	-	-	-	114.37%	Upgrade
Retained Earnings	-343.08	-250.18	-167.84	-121.59	-92.48	-71.66	-55.86	-37.25	-	-47.78	Upgrade
Comprehensive Income	-3.06	-3.86	-1.43	-1.88	-1.93	-1.11	-2.64	-0.08	-	0	Upgrade
Shareholders' Equity	161.03	185.09	257.19	83.75	96.74	27.25	31.33	-37.11	-	-44.18	Upgrade
Net Cash / Debt	142.23	158.99	243.88	66.66	100.81	50.78	30.95	21.76	0	-2.62	Upgrade
Net Cash / Debt Growth	-10.54%	-34.81%	265.88%	-33.88%	98.54%	64.06%	42.21%	-	-	-	Upgrade
Net Cash Per Share	5.10	6.50	12.77	3.76	6.68	4.92	6.66	36.81	-	-59.86	Upgrade
Working Capital	157.29	182.07	254.49	80.98	97.49	36.16	31.18	21.42	-	-2.51	Upgrade
Book Value Per Share	5.77	7.56	13.47	4.72	6.42	2.64	6.74	-62.76	-	-1009.81	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).